| Clark Harris Galbraith, MD | |
|
1600 Lakeland Hills Blvd, Lakeland, FL 33805-3019 | |
| (863) 680-7000 | |
| (866) 264-8519 |
| Full Name | Clark Harris Galbraith |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 26 Years |
| Location | 1600 Lakeland Hills Blvd, Lakeland, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053393454 | NPI | - | NPPES |
| 278077100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME97745 (Florida) | Primary |
| 207L00000X | Anesthesiology | 33804 (Tennessee) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeland Regional Medical Center | Lakeland, FL | Hospital |
| Bartow Regional Medical Center | Bartow, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Watson Clinic Llp | 1456258979 | 373 |
News Archive
An analysis of Medicare payments to home health care companies by The Wall Street Journal indicates that some might be taking advantage of the system. According to the analysis, the industry's largest company, Amedisys Inc., "provided many of its patients just enough therapy visits to trigger the extra $2,200 payment.
Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of small molecules to alleviate multiple chronic human diseases including cystic fibrosis (CF), hypertension and chronic kidney diseases with hypertension.
Medarex, Inc. has announced the allowance of an investigational new drug (IND) application filed with the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company's first Antibody-Drug Conjugate (ADC) candidate generated from its proprietary technology.
› Verified 5 days ago
| Entity Name | Watson Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316940695 PECOS PAC ID: 1456258979 Enrollment ID: O20031215000113 |
News Archive
An analysis of Medicare payments to home health care companies by The Wall Street Journal indicates that some might be taking advantage of the system. According to the analysis, the industry's largest company, Amedisys Inc., "provided many of its patients just enough therapy visits to trigger the extra $2,200 payment.
Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of small molecules to alleviate multiple chronic human diseases including cystic fibrosis (CF), hypertension and chronic kidney diseases with hypertension.
Medarex, Inc. has announced the allowance of an investigational new drug (IND) application filed with the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company's first Antibody-Drug Conjugate (ADC) candidate generated from its proprietary technology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clark Harris Galbraith, MD P.o. Box 95004, Lakeland, FL 33804-5004 Ph: (863) 680-7000 | Clark Harris Galbraith, MD 1600 Lakeland Hills Blvd, Lakeland, FL 33805-3019 Ph: (863) 680-7000 |
News Archive
An analysis of Medicare payments to home health care companies by The Wall Street Journal indicates that some might be taking advantage of the system. According to the analysis, the industry's largest company, Amedisys Inc., "provided many of its patients just enough therapy visits to trigger the extra $2,200 payment.
Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of small molecules to alleviate multiple chronic human diseases including cystic fibrosis (CF), hypertension and chronic kidney diseases with hypertension.
Medarex, Inc. has announced the allowance of an investigational new drug (IND) application filed with the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company's first Antibody-Drug Conjugate (ADC) candidate generated from its proprietary technology.
› Verified 5 days ago
Frances Marie Harris, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Dr. Gordon Wayne Ondra, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 343 Heatherpoint Dr, Lakeland, FL 33809 Phone: 407-808-5928 | |
Tito C. Saldana, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd., Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Dr. Reza Yasrebi, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 352-867-8898 Fax: 352-732-6282 | |
Ramiz Gundkalli, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 352-867-8898 Fax: 352-732-6282 | |
James Allen Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 |